1. Home
  2. VYGR vs SIEB Comparison

VYGR vs SIEB Comparison

Compare VYGR & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • SIEB
  • Stock Information
  • Founded
  • VYGR 2013
  • SIEB 1886
  • Country
  • VYGR United States
  • SIEB United States
  • Employees
  • VYGR N/A
  • SIEB N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • SIEB Investment Bankers/Brokers/Service
  • Sector
  • VYGR Health Care
  • SIEB Finance
  • Exchange
  • VYGR Nasdaq
  • SIEB Nasdaq
  • Market Cap
  • VYGR 165.5M
  • SIEB 148.8M
  • IPO Year
  • VYGR 2015
  • SIEB N/A
  • Fundamental
  • Price
  • VYGR $2.74
  • SIEB $5.43
  • Analyst Decision
  • VYGR Strong Buy
  • SIEB
  • Analyst Count
  • VYGR 8
  • SIEB 0
  • Target Price
  • VYGR $14.33
  • SIEB N/A
  • AVG Volume (30 Days)
  • VYGR 377.3K
  • SIEB 138.3K
  • Earning Date
  • VYGR 05-06-2025
  • SIEB 05-13-2025
  • Dividend Yield
  • VYGR N/A
  • SIEB N/A
  • EPS Growth
  • VYGR N/A
  • SIEB 117.05
  • EPS
  • VYGR N/A
  • SIEB 0.46
  • Revenue
  • VYGR $66,958,000.00
  • SIEB $92,064,000.00
  • Revenue This Year
  • VYGR N/A
  • SIEB N/A
  • Revenue Next Year
  • VYGR $45.34
  • SIEB N/A
  • P/E Ratio
  • VYGR N/A
  • SIEB $11.91
  • Revenue Growth
  • VYGR N/A
  • SIEB 21.82
  • 52 Week Low
  • VYGR $2.65
  • SIEB $1.41
  • 52 Week High
  • VYGR $9.55
  • SIEB $5.53
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 33.88
  • SIEB 77.37
  • Support Level
  • VYGR $2.71
  • SIEB $3.56
  • Resistance Level
  • VYGR $2.99
  • SIEB $4.62
  • Average True Range (ATR)
  • VYGR 0.18
  • SIEB 0.49
  • MACD
  • VYGR -0.05
  • SIEB 0.12
  • Stochastic Oscillator
  • VYGR 10.86
  • SIEB 94.92

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.

Share on Social Networks: